Yayın:
Correction: Structure-based design, synthesis, and biological activity evaluation of chalcone–piperazine derivatives as dual AChE and MAO B inhibitors

dc.contributor.authorBerkant Kurban
dc.contributor.authorBegüm Nurpelin Sağlık
dc.contributor.authorDerya Osmani̇ye
dc.contributor.authorSerkan Levent
dc.contributor.authorYusuf Özkay
dc.contributor.authorZafer Asım Kaplancıklı
dc.contributor.orcid0000-0002-1595-3870
dc.contributor.orcid0000-0002-0151-6266
dc.contributor.orcid0000-0002-0499-436X
dc.contributor.orcid0000-0003-3692-163X
dc.contributor.orcid0000-0001-5948-1855
dc.contributor.orcid0000-0003-2252-0923
dc.date.accessioned2026-05-20T10:05:29Z
dc.date.issued2025-01-01
dc.identifier.doi10.1039/d5ra90135a
dc.identifier.endpage45295
dc.identifier.issn2046-2069
dc.identifier.issue53
dc.identifier.openalexW4416351256
dc.identifier.startpage45295
dc.identifier.urihttps://hdl.handle.net/11421/39341
dc.identifier.urihttps://doi.org/10.1039/d5ra90135a
dc.identifier.volume15
dc.language.isoen
dc.relation.ispartofRSC Advances
dc.rightsopenAccess
dc.subjectBiological activity
dc.subjectAché
dc.subjectDual (grammatical number)
dc.subjectAcetylcholinesterase
dc.subjectStructure–activity relationship
dc.titleCorrection: Structure-based design, synthesis, and biological activity evaluation of chalcone–piperazine derivatives as dual AChE and MAO B inhibitors
dspace.entity.typePublication

Dosyalar

Koleksiyonlar